颈部硬膜外持续注药治疗颈椎间盘突出症临床研究  

Continuous injection in the epidural space to treat the prolapse of cervical intervertebral disc LI Bao-wang

作　　者：李保旺 刘小立[2] 杨长波 王国杰 苏秀芹 张雪光 

机构地区：[1]河北省磁县医院麻醉.疼痛科,056500 [2]河北医科大学第四医院麻醉科

出　　处：《实用疼痛学杂志》2005年第3期149-151,共3页Pain Clinic Journal

摘　　要：目的探讨硬膜外间隙持续注药治疗颈椎间盘突出症的效果。方法患者80例随机分为单次注药组(Ⅰ组)和持续注药组(Ⅱ组),各40例;Ⅰ组采用颈部硬膜外间隙单次注药;Ⅱ组采用颈部硬膜外间隙持续注药,内含曲安奈德,布比卡因等,2ml/h。每周1次,3次为1疗程,并进行VAS评分。结果经3个月随访Ⅱ组患者疼痛减轻程度均优于Ⅰ组(P<0.01)。结论颈部硬膜外间隙持续注药,治疗颈椎间盘突出症疗效确切,优于单次注药。Objective To study the effect of treating prolapse of cervical intervertebral disc with continuous drug injection. Methods 80 patients with prolapse of cervical intervertebral disc were divided into two groups: Group Ⅰ single injection; and Group Ⅱ continuous drug injection, 2ml/h.The mixture used contained triamcinolone, bupivacaine and anisodamine. In group Ⅱ, the drug was continuously injected into cervical epidural space 2 ml/h, one time per week, three times per therapy course.The effect was evaluated with VAS. Results Pain was alleviated more in group Ⅱ than that in group Ⅰ (P<0.01). Conclusion The treatment of prolapse of cervical intervertebral disc with continuous drug injection is reliable compared with single drug injection method.

关 键 词：颈椎间盘突出症 注药治疗 颈部 临床研究 硬膜外间隙 单次注药 持续注药 VAS评分 曲安奈德 布比卡因 注药组 患者 

分 类 号：R681.5[医药卫生—骨科学]